Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Solid Tumor × encorafenib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Melanoma 7 Colonic Neoplasms 5 Rectal Neoplasms 4 Colorectal Neoplasms 4 Skin Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Thyroid Neoplasms 1 Solid Tumor 1 Rectal Diseases 1 Neoplasms 1 Lung Neoplasms 1 Intestinal Neoplasms 1 Intestinal Diseases 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Disease Progression 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colonic Diseases 1

Interventions

pembrolizumab 3 zimberelimab 1 tislelizumab 1 tilsotolimod 1 sintilimab 1 sacituzumab govitecan 1 niraparib 1 encorafenib 1 cobimetinib 1 cedazuridine 1 binimetinib 1 atezolizumab 1 Radiosurgery 1 Proton Therapy 1 Nivolumab 1 Ipilimumab 1 Everolimus 1 Decitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03839342 2025-02-03

BEAVER

University Health Network, Toronto

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡